Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematologic Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT05410574
What this trial is testing

Family-Based Behavioral Treatment for Childhood Survivors of Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
Washington University School of Medicine 17
Large-scale testing (Phase 3)Active Not RecruitingNCT05552976
What this trial is testing

Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Bristol-Myers Squibb 606
Testing effectiveness (Phase 2)Study completedNCT00005040
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)UnknownNCT02457650
What this trial is testing

T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies

Who this might be right for
Bladder CarcinomaBreast CancerEsophagus Carcinoma+7 more
Shenzhen Second People's Hospital 36
Testing effectiveness (Phase 2)Looking for participantsNCT06686108
What this trial is testing

Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transplant Relapse Prevention

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONRelapse
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 59
Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Very early researchLooking for participantsNCT06045091
What this trial is testing

To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL

Who this might be right for
Multiple MyelomaPlasma Cell Leukemia
Hrain Biotechnology Co., Ltd. 18
Testing effectiveness (Phase 2)WithdrawnNCT02973191
What this trial is testing

Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Celgene
Testing effectiveness (Phase 2)Ended earlyNCT03381118
What this trial is testing

Haploidentical Lymphocytes With Nivolumab/Ara-C as Consolidation in Elderly AML Patients

Who this might be right for
Acute Myeloid Leukemia
St. Petersburg State Pavlov Medical University 16
Testing effectiveness (Phase 2)Ended earlyNCT03301597
What this trial is testing

NLA101 in Adults Receiving High Dose Chemotherapy for AML

Who this might be right for
Leukemia, Myeloid, Acute
Nohla Therapeutics, Inc. 146
Early research (Phase 1)Study completedNCT01614197
What this trial is testing

A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma

Who this might be right for
Lymphoblastic Leukemia, Acute, ChildhoodLymphoblastic LymphomaPeripheral T-cell Lymphoma
Therapeutic Advances in Childhood Leukemia Consortium 16
Testing effectiveness (Phase 2)Looking for participantsNCT05194397
What this trial is testing

Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors

Who this might be right for
Lymphoblastic LeukemiaCancer SurvivorsAplastic Anemia+2 more
Children's Hospital of Philadelphia 80
Early research (Phase 1)Study completedNCT05011097
What this trial is testing

A Phase I Clinical Trial of Y150 in the Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Wuhan YZY Biopharma Co., Ltd. 20
Large-scale testing (Phase 3)Ended earlyNCT00416910
What this trial is testing

Combination Chemotherapy With or Without G-CSF in Treating Patients With Relapsed Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 83
Not applicableLooking for participantsNCT06535113
What this trial is testing

Decoding the Inflammasome Influence on Treatment Response in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Ciceri Fabio 80
Testing effectiveness (Phase 2)WithdrawnNCT02371590
What this trial is testing

Lenalidomide and Obinutuzumab for Previously Untreated CLL

Who this might be right for
Chronic Lymphocytic Leukemia
University of California, San Diego
Testing effectiveness (Phase 2)Ended earlyNCT01034410
What this trial is testing

AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Antisoma Research 90
Testing effectiveness (Phase 2)Ended earlyNCT00003113
What this trial is testing

Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas

Who this might be right for
Lymphoma
Case Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Ended earlyNCT03933813
What this trial is testing

Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients

Who this might be right for
Epithelial Ovarian CancerAnemiaIron Deficiency Anemia
University of Wisconsin, Madison 9
Early research (Phase 1)Looking for participantsNCT06909474
What this trial is testing

Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies

Who this might be right for
T-ALL/Lymphoma
Chongqing Precision Biotech Co., Ltd 15
Next Page